Article Text

Download PDFPDF
Systematic review
Meta-analysis of results from case control and cohort studies finds that migraine is associated with approximately twice the risk of ischaemic stroke
  1. John W Cole1,2,
  2. Steven J Kittner1,2
  1. 1Baltimore VA Medical Center, Medical Research Service and Department of Neurology, Baltimore, Maryland, USA
  2. 2University of Maryland School of Medicine, Department of Neurology, Baltimore, Maryland, USA
  1. Correspondence to John W Cole
    Bressler Research Building, Room 12-006, 655 West Baltimore Street, Baltimore, MD 21201-1559, USA; jcole{at}som.umaryland.edu

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on:

Context

Several studies have linked ischaemic stroke with migraine headache. To better define this relationship, investigators performed a meta-analysis to quantitatively summarise the strength of association between migraine and ischaemic stroke risk.

Methods

A systematic search identified relevant published reports regarding ischaemic stroke risk as associated with migraine. Prespecified criteria: (1) included studies with case-control or cohort study designs with reported or extractable adjusted quantitative estimates of the risk of ischaemic stroke in migraineurs compared with non-migraineurs and (2) excluded studies of transient stroke-like syndromes, migrainous infarction, silent infarction and those that reported outcomes as associated with mixed stroke types (eg, haemorrhagic and ischaemic stroke). Of note, all but two studies from the most recent prior meta-analysis1 and nine additional studies were included in the present study. Included studies were required to implement standard definitions, or reasonable variations thereof, for both stroke and migraine.

OR, RR, HR and incidence rate ratios were used to estimate effect sizes. Evaluations of clinical, methodological and statistical heterogeneity of the included studies were assessed using the Cochrane Collaboration Guidelines …

View Full Text

Footnotes

  • Competing interests None.